Peptides antibodies directed thereagainst and methods using same for diagnosing and treating amyloid-associated diseases
AssigneeTel Aviv University Future Technology Development L.P.
InventorEhud Gazit
Life of this patent
Estimating the term…
Abstract
Peptides having at least 2 amino acids and no more than 15 amino acids are provided. The peptides comprise amino acid sequence X-Y or Y-X, wherein X is an aromatic amino acid and Y is any amino acid other than glycine. Also provided are pharmaceutical compositions and kits including such peptides as well as methods using same for diagnosing and treating amyloid associated diseases.
Claims8
A peptide as set forth in SEQ ID NO:
- 145.
A pharmaceutical composition comprising as an active ingredient a peptide as set forth in SEQ ID NO:
- 145 and a pharmaceutically acceptable carrier or diluent.
A method of treating or preventing an amyloid-associated disease in an individual, the method comprising providing to the individual a therapeutically effective amount of a peptide as set forth in SEQ ID NO:
- 145, thereby treating or preventing an amyloid-associated disease in the individual.
Dependencies are inferred from the claim text.